tetrahydrozoline hydrochloride Ophthalmic solution 3 mg

This CTD dossier owner and manufacturer is a pharmaceutical enterprise with over four decades of experience producing and distributing a diverse range of products. They offer over 200 products spanning eight categories, including prescription medications, over-the-counter drugs, functional foods, medical devices, and supplements. Their key therapeutic areas include (information not provided), and they primarily utilize dosage forms such as (information not provided). The company has a robust distribution network spanning across the EU and North America, reaching hospitals, clinics, pharmacies, and agents. They hold GMP-WHO certifications for their manufacturing facilities located in (information not provided), further emphasizing their commitment to quality and regulatory compliance.